INS and type 2 diabetes mellitus: Diverse genetic defects in GCK lead to different kinds of insulin secretion phenotypes, resulting in a range of disease severity, from neonatal diabetes and MODY, to increased T2D risk and congenital hyperinsulinism (18, 19, 49).